Positive impact of protease inhibitors on body composition and energy expenditure in HIV-infected and AIDS patients

Annals of the New York Academy of Sciences

Volumn 904, Issue , 2000, Pages 603-606

  Schindler, K ^a   Pernerstorfer Schoen, H ^b   Schneider, B ^b   Rieger, A ^b   Elmadfa, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NELFINAVIR; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS LOAD; WEIGHT GAIN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034084741     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06522.x     Document Type: Conference Paper

References (5)

1. CARBONNEL, F. et al. 1998. Effect of indinavir on HIV-related wasting. AIDS 12: 1777-1784.
2. SILVA, M. et al. 1998. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12: 1645-1651.
3. DULLOO, A.G. et al. 1996. Autoregulation of body composition during weight recovery in human: the Minnesota Experiment revisited. Int. J. Obes. Relat. Metab. Disord. 20: 393-405.
4. SHEVITZ, A. et al. 1998. In Twelvth World AIDS Conference, Geneva. Abstr. 32168.
5. MULLIGAN, K. et al. 1997. Energy expenditure in human immunodeficiency virus infection. N. Engl. J. Med. 336: 70-71.